Cargando…
LncRNA Gm12664–001 ameliorates nonalcoholic fatty liver through modulating miR-295-5p and CAV1 expression
BACKGROUND: Our study aims to investigate the mechanisms of lncRNA Gm12664–001 improved hepatic lipid accumulation-initiated NAFLD via regulating miR-295-5p and CAV1 in AML12 cells. METHODS: The animals were divided into normal control (NC) group and high fat diet (HFD) group (20 mice per group) for...
Autores principales: | Zhang, Qiao, Wang, Jiemei, Li, Hongyin, Zhang, Yuan, Chu, Xia, Yang, Jianjun, Li, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001338/ https://www.ncbi.nlm.nih.gov/pubmed/32042299 http://dx.doi.org/10.1186/s12986-020-0430-z |
Ejemplares similares
-
Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
por: Yuan, Xinlu, et al.
Publicado: (2015) -
lncRNA-GM targets Foxo1 to promote T cell–mediated autoimmunity
por: Chen, Yali, et al.
Publicado: (2022) -
Oscillating lncRNA Platr4 regulates NLRP3 inflammasome to ameliorate nonalcoholic steatohepatitis in mice
por: Lin, Yanke, et al.
Publicado: (2021) -
Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum
por: Lee, Na Young, et al.
Publicado: (2020) -
The function and clinical relevance of lncRNA UBE2CP3-001 in human gliomas
por: Luo, Zhengxiang, et al.
Publicado: (2018)